Medical Device Network on MSN

ADA26: Dexcom’s G7 CGM helps TD2 diabetics not on insulin manage glucose levels

Dexcom anticipates that the findings could drive a shift in the standard of care for type 2 diabetes patients who do not use insulin.
Zacks Investment Research on MSN

Dexcom reports positive CONNECT data for non-insulin diabetes

DexCom, Inc. DXCM recently announced positive results from its CONNECT randomized controlled trial, demonstrating that use of ...
Drug Delivery Business

Dexcom study highlights benefits of G7 CGM in non-insulin type 2 diabetes

Researchers shared findings today at the American Diabetes Association Scientific Sessions (ADA 2026) in New Orleans. San ...

Dexcom CONNECT Study: The Most Significant Clinical Study Demonstrating CGM Benefits for ...

DexCom, Inc. (NASDAQ:DXCM) announced today results from the CONNECT randomized controlled trial, demonstrating the use of ...